NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

Rhea-AI Summary

NeuroOne Medical Technologies (Nasdaq: NMTC), a medical technology company specializing in neurological disorder treatments, has announced its participation in The ThinkEquity Conference on October 30, 2024. The event will be held at the Mandarin Oriental Hotel in New York. CFO Ron McClurg will deliver a presentation at 9:00 am ET, and the company will conduct one-on-one investor meetings throughout the day. The conference brings together institutional investors, corporate clients, and industry professionals to showcase innovations and financial strategies. The presentation will be available via live stream, and interested investors can register to attend and schedule meetings.

EDEN PRAIRIE, Minn., Oct. 24, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies.

Ron McClurg, CFO, will be presenting at 9:00 am ET on October 30^th. The Company will also hold one-on-one investor meetings throughout the day. Interested investors can register to attend and schedule on-on-one meetings here.

The presentation will also be live-streamed at the following link: https://wsw.com/webcast/tep25/nmtc/1682208.

About ThinkEquity
ThinkEquity is a boutique investment bank founded by professionals who have collaborated for over a decade, collectively financing over $50 billion in public and private capital raises, restructurings, and mergers and acquisitions. Past ThinkEquity conferences have featured over 70 company presentations, 700+ attendees, and 500+ one-on-one meetings, providing a valuable platform for companies and investors to connect. To register to attend The ThinkEquity Conference, please follow this link.

About NeuroOne
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.

IR Contact
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group – MZ North America
NMTC@mzgroup.us
(949) 694-9594

FAQ

When is NeuroOne Medical Technologies (NMTC) presenting at the 2024 ThinkEquity Conference?

NeuroOne Medical Technologies (NMTC) will present at 9:00 am ET on October 30, 2024, at the ThinkEquity Conference.

Where can investors watch NeuroOne's (NMTC) ThinkEquity Conference presentation?

Investors can watch the live stream of NeuroOne's presentation at https://wsw.com/webcast/tep25/nmtc/1682208.

What type of meetings will NeuroOne (NMTC) hold at the 2024 ThinkEquity Conference?

NeuroOne will hold one-on-one investor meetings throughout the day at the conference.

Where is the 2024 ThinkEquity Conference being held?

The 2024 ThinkEquity Conference is being held at the Mandarin Oriental Hotel in New York.